Back

The histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pathomechanisms of heart failure with preserved ejection fraction Heart Failure ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Samuele Ambrosini

University of Zurich, Schlieren (Switzerland)

6 More presentations in this session

Presentation thumbnail
The role of endothelial adipose triglyceride lipase (ecATGL) in heart failure with preserved ejection fraction (HFpEF)
Doctor J. Schwanbeck (Berlin, DE)
Abstract Slides
Presentation thumbnail
Alterations in the gut microbiota composition in the obesity phenotype of heart failure with preserved ejection fraction
Mr Y. Rokach (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Induction of periodontitis and oral microbiome dysbiosis in a mouse model with heart failure with preserved ejection fraction results in worsening hypertension and diastolic dysfunction
Ms S. Daana (London, GB)
Abstract Slides
Presentation thumbnail
Enhancing NO pathway improves diastolic function in a hamster model of heart failure with preserved ejection fraction associated with nonalcoholic steatohepatitis
Doctor C. Dubroca (Escalquens, FR) Doctor F. Briand (FR)
Abstract Slides
Presentation thumbnail
Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction
Mrs I. Vasconcelos (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Pathomechanisms of heart failure with preserved ejection fraction

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Basic science
thumbnail
Congress Presentation
European Heart Journal
thumbnail
Congress Presentation
ESC Textbook of Heart Failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources